| Brandon Fetterolf, DO | |
|
Madigan Army Medical Center, 9040 Fitzsimmons Dr, Tacoma, WA 98431 | |
| (989) 859-3260 | |
| Not Available |
| Full Name | Brandon Fetterolf |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | Madigan Army Medical Center, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679815195 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2017-01929 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-northeast | Concord, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Carolinas Emergency Group, Pllc | 2567486814 | 73 |
| Carolinas Medical Center | 4789597477 | 735 |
| Wake Forest Emergency Providers | 7012819816 | 218 |
News Archive
Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Latest survey shows steep rise in students attending schools with access to drugs.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
› Verified 1 days ago
| Entity Name | Carolinas Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774333 PECOS PAC ID: 4789597477 Enrollment ID: O20031110000116 |
News Archive
Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Latest survey shows steep rise in students attending schools with access to drugs.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
› Verified 1 days ago
| Entity Name | The Carolinas Emergency Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477508836 PECOS PAC ID: 2567486814 Enrollment ID: O20060125000577 |
News Archive
Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Latest survey shows steep rise in students attending schools with access to drugs.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
› Verified 1 days ago
| Entity Name | Wake Forest Emergency Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396216735 PECOS PAC ID: 7012819816 Enrollment ID: O20190312003619 |
News Archive
Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Latest survey shows steep rise in students attending schools with access to drugs.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
› Verified 1 days ago
| Entity Name | Ballantyne Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164052726 PECOS PAC ID: 8123459898 Enrollment ID: O20200513000736 |
News Archive
Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Latest survey shows steep rise in students attending schools with access to drugs.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
› Verified 1 days ago
| Entity Name | Stallings Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235728031 PECOS PAC ID: 2769870971 Enrollment ID: O20211020002403 |
News Archive
Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Latest survey shows steep rise in students attending schools with access to drugs.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandon Fetterolf, DO Madigan Army Medical Center, 9040 Fitzsimmons Dr, Tacoma, WA 98431 Ph: (989) 859-3260 | Brandon Fetterolf, DO Madigan Army Medical Center, 9040 Fitzsimmons Dr, Tacoma, WA 98431 Ph: (989) 859-3260 |
News Archive
Researchers have discovered how our choice of diet can weaken our gut immune system and lead to the development of diabetes.
Boston Scientific Corporation today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in the European Union and other CE Mark countries. The TAXUS Element Stent System is the Company's third-generation drug-eluting stent (DES) technology and incorporates a platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. It received CE Mark approval last month, which included a specific indication for the treatment of diabetic patients.
Latest survey shows steep rise in students attending schools with access to drugs.
Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.
› Verified 1 days ago
Dr. Justin Cha-cheng Ng, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-2050 | |
Robert F Wachtel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Dr. Nathan Kinneer Friedline, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98433 Phone: 850-885-2273 | |
Barbara Sherry Mezger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3400 Fax: 253-596-3301 | |
Dr. Peter Stull, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1250 Fax: 253-968-2550 | |
Kevin E Callahan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
June A Burn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14815 Pacific Ave S, Tacoma, WA 98444 Phone: 253-697-8660 |